Introduction
scopy) within glomerular capillaries on frozen cuttings, onset of fibrosis, mixed inflammatory infiltrate and Foscarnet nephrotoxicity usualy consists in early epithelial crescents. Polarized infrared microscopy reversible renal tubular injury, in immunocompromised identified the crystals as precipitates of foscarnet patients. Neurotoxicity of this drug is uncommon. We ( Figure 1 ). Electron microscopy localized crystals in report the case of an immunocompetent 41-year-old the cytoplasm of epithelial cells (Figure 2 ). Forty-five woman without underlying disease, who was treated days after haemodialysis was started, renal function with foscarnet for severe herpes kerato-uveitis and had had not recovered and a second biopsy was performed, serious adverse effects.
showing extensive renal sclerosis. Immune complexes were not detected on renal biopsies. In June, recurrent fever appeared and endocarditis
Case
was diagnosed by transoesophageal echocardiography. Staphylococcus epidermidis was isolated from the endoIn September 1995 an immunocompetent 41-year-old prosthesis that had been used for foscarnet infusions. woman with an unremarkable medical history was Four months intravenous treatment with fosfomycin treated with acyclovir (16 mg/kg/day) for 11 months for (6 g/week) and teicoplanin (0.7 g/week) was successful. severe herpes kerato-uveitis. Herpes recurred in August
In March 1998, renal function improved: glomer-1996 and to prevent blindness, intravenous foscarnet ular filtration reached 15 ml/min and dialysis was was administered after verification of renal function withdrawn. (serum creatinine 80 mmol/l ) and prehydration, at an initial dose of 200 mg/kg/day, which was decreased to 100 mg/kg/day (total cumulative dose 1.5 kg).
In January 1997 the patient had polyneuritis with sensory impairment of all four extremities and absence of tendon jerks. Neurological symptomatology increased during foscarnet infusions. Electromyography demonstrated symmetrical sensory neuropathy and neuromuscular biopsy revealed myelin breakdown and axonal degeneration. Electron microscopy showed clear round inclusions with peripheral condensations in Schwann cells and histiocytes of peripheral nerves. Clonazepam improved the neurological symptoms. An electromyogram performed 6 months later showed that the polyneuritis continued to progress.
In April 1997, despite adequate hydration, renal failure occurred (serum creatinine 210 mmol/l ), with proteinuria (2 g/day) and haematuria (30 000 red Foscarnet inhibits viral DNA polymerases and reverse with crystalline deposits and peripheral neuropathy, transcriptase, while most antiretrovirals are nucleoside assumed to be AIDS related, with partial recovery of analogues. Normal neurological status before therapy, renal function, has been reported [2] . Foscarnet absence of underlying disease or concurrent treatment, nephrotoxicity, predominantly affecting immunocomappearance of symptoms during treatment, the high promised patients, usually consists of early reversible cumulative dose, and the unusual histological aspect renal tubular injury [3, 4] . Prehydration with 2.5 l/day support the hypothesis that foscarnet caused this polyof isotonic saline during foscarnet therapy greatly neuritis. Foscarnet may have altered peripheral-nerve reduces the risk of acute tubular necrosis [3] . metabolism, leading to the observed myelin destrucThe case of our patient was quite different. Adequate tion, axonal degeneration and vacuole formation in prehydration was employed, the onset of renal failure Schwann cells and histiocytes. was delayed, the nephropathy was glomerular and renal function recovery was mild. The evidence indicating foscarnet therapy as the cause of renal failure include: (i) normal renal function before administra-References tion of foscarnet and its deterioration during the 1994; 28: 1035-1037 Neurotoxicity ascribed to foscarnet is uncommon,
